Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Clorox (CLX) and CVS Health (CVS).
Clorox (CLX)
Barclays analyst Lauren Lieberman maintained a Sell rating on Clorox yesterday and set a price target of $189.00. The company’s shares closed last Tuesday at $237.74, close to its 52-week high of $238.41.
According to TipRanks.com, Lieberman is a 1-star analyst with an average return of -1.5% and a 50.3% success rate. Lieberman covers the Consumer Goods sector, focusing on stocks such as International Flavors & Fragrances, Coca-Cola European Partners, and The Estée Lauder Companies.
Currently, the analyst consensus on Clorox is a Hold with an average price target of $220.89, representing a -4.7% downside. In a report released yesterday, Morgan Stanley also maintained a Sell rating on the stock with a $197.00 price target.
See today’s analyst top recommended stocks >>
CVS Health (CVS)
Oppenheimer analyst Michael Wiederhorn maintained a Hold rating on CVS Health today. The company’s shares closed last Tuesday at $64.98.
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 17.5% and a 71.4% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as Community Health, The Ensign Group, and HCA Healthcare.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for CVS Health with a $74.71 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
